Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationJ Minim Invasive Gynecol 15 (1):26-31
AbstractSTUDY OBJECTIVE: We sought to estimate effectiveness of transdermal scopolamine to prevent postoperative nausea and vomiting after gynecologic laparoscopy. DESIGN: Patients were randomized to receive preoperative transdermal scopolamine or placebo. Main outcome measure was incidence of nausea during the first 24 hours postoperatively. Wilcoxon rank sum, Student t, chi(2), and Fischer exact tests were used for data analysis (Canadian Task Force classification IA). SETTING: Academic teaching hospital. PATIENTS: A total of 48 patients undergoing gynecologic laparoscopy were studied. INTERVENTIONS: Randomized administration of transdermal Scopolamine or placebo in patients having gynecologic laparoscopic surgery. MEASUREMENTS AND MAIN RESULTS: Patients in the scopolamine group had significantly less incidence of nausea (20.8% vs 62.5%, p = .003) and vomiting (8.3% vs 37.5%, p = .016) during the first 24 hours after surgery. Number needed to treat was 3 (95% CI 1.5, 6.1) for nausea and 4 (95% CI 1.9, 14.6) for vomiting. Symptoms of visual disturbance and dry mouth were more common in the scopolamine group. CONCLUSION: Scopolamine patch significantly reduces incidence and severity of nausea and vomiting in the first 24 hours after gynecologic laparoscopic surgery.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
- Authors: Gan TJ, Sinha AC, Kovac AL, Jones RK, Cohen SA, Battikha JP, Deutsch JS, Pergolizzi JV Jr, TDS Study Group., Glass PS
- Issue date: 2009 May
- [Transdermal scopolamine for prevention of postoperative nausea and vomiting. No clinically relevant result in spite of reduced postoperative vomiting in general surgical and gynecologic patients].
- Authors: Eberhart LH, Holzrichter P, Roscher R
- Issue date: 1996 Mar
- A randomized blinded study of the incidence of postoperative nausea and vomiting in women after major gynecologic laparoscopic surgery.
- Authors: Tseng LH, Liou SC, Chang TC, Tsai SC, Soong YK, Wong SY
- Issue date: 2006 Sep-Oct
- Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery.
- Authors: Sah N, Ramesh V, Kaul B, Dalby P, Shestak K, Vallejo MC
- Issue date: 2009 Jun
- Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.
- Authors: White PF, Tang J, Song D, Coleman JE, Wender RH, Ogunnaike B, Sloninsky A, Kapu R, Shah M, Webb T
- Issue date: 2007 Jan